Interferon Alpha (NSC# 377523) Plus 13-Cis-Retinoic Acid Modulation Of BCL-2 Plus Paclitaxel For Recurrent Small Cell Lung Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interferon alpha; Isotretinoin; Paclitaxel
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 08 Oct 2015 Biomarkers information updated
- 02 Feb 2010 Planned number of patients changed from 37 to 83 as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.